Search clinical trials for: Visilizumab
Total 14 results
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia | Refractory Leukemia | Immunotherapy | Relapsed Adult AMLChina
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedGraft Versus Host DiseaseUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedLymphoma | Small Intestine CancerUnited States
-
AbbottTerminatedUlcerative ColitisUnited States, Canada, Croatia, Italy, Russian Federation, Spain
-
Facet BiotechCompletedGraft vs Host DiseaseUnited States
-
Facet BiotechPDL BioPharma, Inc.TerminatedUlcerative ColitisFrance, Belgium, United States, Israel, Australia, Germany, Netherlands, Austria, Canada, Czech Republic, Ukraine, Norway, Hungary, Slovakia
-
Facet BiotechPDL BioPharma, Inc.TerminatedUlcerative ColitisBelgium, France, United States, Italy, Canada, Czech Republic, Norway, Israel, Austria, Croatia, Australia, Hungary, Ukraine, Netherlands, Germany
-
Facet BiotechPDL BioPharma, Inc.CompletedSevere Ulcerative ColitisUnited States
-
Facet BiotechPDL BioPharma, Inc.CompletedCrohn's DiseaseUnited States
-
Facet BiotechCompleted
-
Facet BiotechPDL BioPharma, Inc.Completed
-
Facet BiotechPDL BioPharma, Inc.WithdrawnIntravenous Steroid-Refractory Ulcerative Colitis
-
PDL BioPharma, Inc.TerminatedUlcerative ColitisBelgium, France, United States, Italy, Australia, Czech Republic, Netherlands, Ireland, Norway, Canada, Austria, Germany, Hungary, Ukraine
-
Fred Hutchinson Cancer CenterFacet BiotechUnknownGraft-vs-Host DiseaseUnited States